MetaCap

Dr. Reddy's Laboratories Statistics

NYSE: RDYHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.27-0.22 (-1.76%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Dr. Reddy's Laboratories by the numbers

Dr. Reddy's Laboratories has a market capitalization of $10.22 billion based on 832.99M shares outstanding. Its trailing P/E ratio is 28.5, below the 3-company peer median of 134.2, and its forward P/E is 19.0. The stock trades 0.9% above its 50-day average and 7.6% below its 200-day average.

Average daily trading volume is 2.89M shares, or about $35.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RDY valuation vs. peer median

RDY compared with the median of 8 peer companies
MetricRDYPeer medianDifference
Market cap$10.22B$9.09B+12%
P/E (TTM)28.5134.2-79%
Forward P/E19.019.6-3%
Avg. volume2.89M1.93M+50%

Peer median across 8 companies: BMRN, ELAN, MDGL, PTGX, AXSM, ARWR, CYTK, TGTX.

Valuation

Market cap
$10.22B
Price / sales (latest FY)
2.68

Price and trading

Previous close
12.49
Open
12.40
Day range
12.22 – 12.37
52-week range
11.36 – 15.67
52-week change
-12.54%
Beta
—
Volume
3.12M

Dividends and events

Annual dividend
$8.00
Next earnings date
Oct 23, 2026

Additional statistics

Market Cap
10.22B
Pe
28.53
Forward Pe
19.05
Eps
0.43
Dividend Yield
68.00%
Dividend Rate
8.00
Week52 High
15.67
Week52 Low
11.36
Avg Volume
2.89M
Shares Outstanding
832.99M
Ma50
12.16
Ma200
13.27
Earnings Date
Oct 23, 2026
Pct From52w High
-21.70%
Pct From52w Low
8.01%

Related